Shares of cannabis stocks are trading higher on continued strength after the HHS last week called for moving marijuana to a lower-risk drug category.
Portfolio Pulse from Benzinga Newsdesk
Cannabis stocks are trading higher following the Health and Human Services' (HHS) call last week to reclassify marijuana as a lower-risk drug. This includes stocks such as AC, AKAN, CGC, CRON, GRWG, IGC, KERN, LFLY, MSOS, SNDL, and TLRY.
September 05, 2023 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AC's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like AC, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
AKAN's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like AKAN, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
CGC's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like CGC, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
CRON's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like CRON, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
GRWG's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like GRWG, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
IGC's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like IGC, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
KERN's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like KERN, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
LFLY's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like LFLY, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
MSOS's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like MSOS, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SNDL's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like SNDL, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
TLRY's stock is trading higher due to the HHS's call to reclassify marijuana as a lower-risk drug.
The HHS's call to reclassify marijuana as a lower-risk drug is a positive development for cannabis companies like TLRY, potentially leading to increased sales and profitability.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100